Health

ABC and CBS Give No Credit to Novartis

Evening broadcasts praise 'promising' drug for osteoporosis without naming the manufacturer.

The 'Consumer Group' That Doesn't Want You to Consume

Journalists love CSPI's hype and embrace its extremist anti-food agenda.

A Rarely Seen Side of the Tobacco Story

WSJ shows one alternative to tobacco is ... tobacco?

Cancer Drug, But Not Drug Company, Praised By Networks

ABC, CBS, NBC discuss 'lifesaver' drug but never mention its maker.

CBS Downplays Costs, Advocates Company's 'Elder Care' Benefits

'Evening News' says cost is 'just $15 a day,' urges workers to ask for more benefits.

ABC Reports New Autism Study Finds Genetics, Not Toxins, to Blame for Rise in Cases

But network failed to remind viewers it gave Robert Kennedy a soapbox about mercury as cause for disease.

Slanting the Cervical Cancer Vaccine Story

"Groups wary of drug industry motives" versus "religious and cultural conservatives." What, no liberals?

Post's Givhan Continues Complaint about Skinny Models

Writer attacks industry for thin model preference, but could just as well gripe about customers who drive the New York market.

NY Times Slants Patent Protection Story Against Novartis

Reporter depicts court struggle as one pitting company against 'patients rights groups' instead of liberal activists.

CBS Obesity Story Heavy on Hype, Light On Substance

Reporter Thalia Assuras fails to inform audience of the limitations of body mass index in diagnosing, treating childhood obesity.
Syndicate content